Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor
David A. Perrey, Nadezhda German, Brian P. Gilmour, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 17, pp. 6901-6916
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis
Valentine G. Nenajdenko, Vasiliy M. Muzalevskiy, А. В. Шастин
Chemical Reviews (2015) Vol. 115, Iss. 2, pp. 973-1050
Closed Access | Times Cited: 132
Effects of the Trace Amine-Associated Receptor 1 Agonist RO5263397 on Abuse-Related Effects of Cocaine in Rats
David A. Thorn, Jing Li, Yanyan Qiu, et al.
Neuropsychopharmacology (2014) Vol. 39, Iss. 10, pp. 2309-2316
Open Access | Times Cited: 84
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015)
Inder Pal Singh, Purvi Shah
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 1, pp. 17-36
Closed Access | Times Cited: 83
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
Organocatalytic Enantioselective Pictet–Spengler Approach to Biologically Relevant 1-Benzyl-1,2,3,4-Tetrahydroisoquinoline Alkaloids
Andrea Ruiz‐Olalla, Martien A. Würdemann, Martin J. Wanner, et al.
The Journal of Organic Chemistry (2015) Vol. 80, Iss. 10, pp. 5125-5132
Open Access | Times Cited: 61
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Therapeutics development for addiction: Orexin-1 receptor antagonists
David A. Perrey, Yanan Zhang
Brain Research (2018) Vol. 1731, pp. 145922-145922
Open Access | Times Cited: 55
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)
Nadezhda German, Ann M. Decker, Brian P. Gilmour, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 18, pp. 7758-7769
Open Access | Times Cited: 43
Synthesis of Tetrahydroisoquinoline Alkaloids and Related Compounds through the Alkylation of Anodically Prepared α-Amino Nitriles
Lotfi Benmekhbi, Fadila Louafi, Thierry Roisnel, et al.
The Journal of Organic Chemistry (2016) Vol. 81, Iss. 15, pp. 6721-6739
Closed Access | Times Cited: 38
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling
K. A. Levy, Zachary D. Brodnik, Jessica K. Shaw, et al.
Psychopharmacology (2017) Vol. 234, Iss. 18, pp. 2761-2776
Open Access | Times Cited: 32
An Update on Assessment, Therapeutic Management, and Patents on Insomnia
Amit Porwal, Yogesh Chand Yadav, Kamla Pathak, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 21
New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds
Martin Nimczick, Michael Decker
ChemMedChem (2015) Vol. 10, Iss. 5, pp. 773-786
Closed Access | Times Cited: 28
Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights
Zachary D. Brodnik, I. Pamela Alonso, Wei Xu, et al.
Brain Research (2018) Vol. 1731, pp. 145894-145894
Closed Access | Times Cited: 27
Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers
David A. Perrey, Brian P. Gilmour, Brian F. Thomas, et al.
ACS Medicinal Chemistry Letters (2014) Vol. 5, Iss. 6, pp. 634-638
Open Access | Times Cited: 26
Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
Guo‐Liang Lu, Amy S.T. Tong, Daniel Conole, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 22, pp. 115784-115784
Open Access | Times Cited: 19
An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis
Lakshmi Mounika Kelam, Mushtaq Ahmad Wani, Devendra K. Dhaked
Progress in Biophysics and Molecular Biology (2023) Vol. 180-181, pp. 87-104
Closed Access | Times Cited: 6
The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A. Perrey, Ann M. Decker, Jun‐Xu Li, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 17, pp. 5709-5724
Open Access | Times Cited: 17
Synthesis and biological evaluation of F-18 labeled tetrahydroisoquinoline derivatives targeting orexin 1 receptor
Hiroyuki Watanabe, Kengo Fukui, Yoichi Shimizu, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 13, pp. 1620-1623
Closed Access | Times Cited: 15
Effect of 1-Substitution on Tetrahydroisoquinolines as Selective Antagonists for the Orexin-1 Receptor
David A. Perrey, Nadezhda German, Ann M. Decker, et al.
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 4, pp. 599-614
Open Access | Times Cited: 14
Berbamine Analogs Exhibit Differential Protective Effects From Aminoglycoside-Induced Hair Cell Death
Alexandria M. Hudson, Gavin Lockard, Ojas A. Namjoshi, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 12
Hypocretin / Orexin Receptor 1 Knockdown in GABA or Dopamine Neurons in the Ventral Tegmental Area Differentially Impact Mesolimbic Dopamine and Motivation for Cocaine
Emily Black, Shanna B. Samels, Wei Xu, et al.
Addiction Neuroscience (2023) Vol. 7, pp. 100104-100104
Open Access | Times Cited: 4
Hypocretin Receptor 1 Blockade Early in Abstinence Prevents Incubation of Cocaine Seeking and Normalizes Dopamine Transmission
P. J. Clark, Volodar M. Migovich, Sanjay Das, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Discovery of Novel Proline-Based Neuropeptide FF Receptor Antagonists
Thuy Nguyen, Ann M. Decker, Tiffany L. Langston, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 10, pp. 2290-2308
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top